Methanolysis products of disorazole A 1

Journal of Natural Products

Volumn 69, Issue 1, 2006, Pages 148-150

  Hearn, Brian R ^a,b   Arslanian, Robert L ^a,b   Fu, Hong ^a,b   Liu, Fenghua ^a,b   Gramajo, Hugo ^a,b   Myles, David C ^a,b  

^a Kasan Biosciences Inc   (United States)

^b Department of Chemistry ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACID; ANTINEOPLASTIC AGENT; DISORAZOLE A1; DISORAZOLE DERIVATIVE; EPOXIDE; KOS 1903; KOS 2296; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL PROLIFERATION; DRUG SENSITIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; METHANOLYSIS; NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; EPOXY COMPOUNDS; MACROLIDES; METHANOL; MOLECULAR STRUCTURE; MYXOCOCCALES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OXAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 32644438966     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np050367n     Document Type: Article

References (15)

1. Jansen, R.; Irschik, H.; Reichenbach, H.; Wray, V.; Höfle, G. Liebigs Ann. Chem. 1994, 759-773.
2. (a) Irschik, H.; Jansen, R.; Gerth, K.; Höfle, G.; Reichenbach, H. J. Antibiot. 1995, 48, 31-35.
3. (b) Elnakady, Y. A.; Sasse, F.; Lünsdorf, H.; Reichenbach, H. Biochem. Pharmacol. 2004, 67, 927-935.
4. (a) Kopp, M.; Irschik, H.; Pradella, S.; Müller, R. ChemBioChem 2005, 6, 1277-1286.
5. (b) Carvalho, R.; Reid, R.; Viswanathan, N.; Gramajo, H.; Julien, B. Gene 2005, 359, 91-98.
6. (a) Hillier, M. C.; Park, D. H.; Price, A. T.; Ng, R.; Meyers, A. I. Tetrahedron Lett. 2000, 41, 2821-2824.
7. (b) Millier, M. C.; Price, A. T.; Meyers, A. I. J. Org. Chem. 2001, 66, 6037-6045.
8. (c) Hartung, I. V.; Niess, B.; Haustedt, L. O.; Hoffmann, H. M. R. Org. Lett. 2002, 4, 3239-3242.
9. (d) Haustedt, L. O.; Panicker, S. B.; Kleinert, M.; Hartung, I. V.; Eggert, U.; Niess, B.; Hoffmann, H. M. R. Tetrahedron 2003, 59, 6967-6977.
10. (e) Wipf, P.; Graham, T. H. J. Am. Chem. Soc. 2004, 126, 15346-15347.
11. Baasner, S.; Gerlach, M.; Hoefle, G.; Mueller, G.; Paulini, K.; Polymeropoulos, E.; Sasse, F.; Schmidt, P.; Guenther, E. G. Disorazol E1 - A Natural Compound with Outstanding In Vitro Antitumor Activity. Presented at American Association for Cancer Research, 2003; Poster #2117.
12. Höfle, G. GBF Annual Report; 1999/2000, pp 102-103.
13. 13C NMR (100 MHz) δ 17.9 (double intensity, C-19 and C-19′).
14. 6, ref 1.
15. 50 values for 1, ref 2.